Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 5;11(7):1529.
doi: 10.3390/nu11071529.

Intra-Abdominal Fat Adipocyte Hypertrophy through a Progressive Alteration of Lipolysis and Lipogenesis in Metabolic Syndrome Rats

Affiliations

Intra-Abdominal Fat Adipocyte Hypertrophy through a Progressive Alteration of Lipolysis and Lipogenesis in Metabolic Syndrome Rats

Israel Pérez-Torres et al. Nutrients. .

Abstract

This study evaluates the progressive participation of enzymes involved in lipolysis and lipogenesis, leading to adipocyte hypertrophy in a metabolic syndrome (MS) rat model caused by chronic consumption of 30% sucrose in drinking water. A total of 70 male Wistar rats were divided into two groups: C and MS. Each of these groups were then subdivided into five groups which were sacrificed as paired groups every month from the beginning of the treatment until 5 months. The intra-abdominal fat was dissected, and the adipocytes were extracted. Lipoprotein lipase (LPL), hormone-sensitive lipase (HSL), protein kinases A (PKA), and perilipin A expressions were determined. The LPL and HSL activities were evaluated by spectrophotometry. Histological staining was performed in adipose tissue. Significant increases were observed in blood pressure, HOMA-IR, leptin, triglycerides, insulin, intra-abdominal fat, and number of fat cells per field (p = 0.001) and in advanced glycosylation products, adipocyte area, LPL, HSL activities and/or expression (p ≤ 0.01) in the MS groups progressively from the third month onward. Lipogenesis and lipolysis were increased by LPL activity and HSL activity and/or expression. This was associated with hyperinsulinemia and release of non-esterified fatty acids causing a positive feedback loop that contributes to the development of adipocyte hypertrophy.

Keywords: adipocyte; hormone-sensitive lipase; hypertrophy; lipoprotein lipase; metabolic syndrome; perilipin A.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Representative histograms: (A) intra-abdominal fat. (B) Fat cell number per gram of tissue. (C) Adipocyte cell number for field and (D) adipocyte diameter. Data show the mean ± SEM; n = 7 rats per experimental group. Abbreviations: C = Control; MS = Metabolic syndrome; M = Month.
Figure 2
Figure 2
Representative photomicrographs of intra-abdominal white tissue from the experimental groups that show adipocyte size. Five fields per sample were analyzed. Panels (A) 1 M, (B) 2 M, (C) 3 M, (D) 4 M and (E) 5 M represent the C, and panels (F) 1 M, (G) 2 M, (H) 3 M, (I) 4 M and (J) 5 M represent the MS groups. n = 7 rats per experimental group. Abbreviations: C = Control; MS = Metabolic syndrome; M = Month.
Figure 3
Figure 3
Effect of 30% chronic sucrose on the LPL (A) and HSL (B) activities through the five months of the treatment determined in the adipocyte homogenates in the experimental groups. Values are the mean ± SEM, n = 7 rats per experimental group. Abbreviations: C = Control; MS = Metabolic syndrome; LPL = Lipoprotein lipase; M = Month; HSL = Hormone sensitive lipase.
Figure 4
Figure 4
Representative histograms of the PKA/GAPDH expression (A) and Perilipin A/GAPDH expression (B). Values are the mean ± SEM n = 7 rats per experimental group. Abbreviations: C = Control; MS = Metabolic syndrome; PKA = Protein kinase A; GAPDH = Glyceraldehyde-3-phosphate dehydrogenase; M = Month.
Figure 5
Figure 5
Representative histograms of HSL/GAPDH expression (A) and LPL/GAPDH expression (B). Values are the mean ± SEM, n = 7 rats per experimental group. Abbreviations: C = Control; MS = Metabolic syndrome; LPL = Lipoprotein lipase; M = Month; HSL = Hormone sensitive lipase.

References

    1. Lorenzo C., Williams K., Hunt K.J., Haffner S.M. The National Cholesterol Education Program Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic. syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007;30:8–13. doi: 10.2337/dc06-1414. - DOI - PubMed
    1. Lafontan M. Adipose tissue and adipocyte dysregulation. Diabetes Metab. 2014;40:16–28. doi: 10.1016/j.diabet.2013.08.002. - DOI - PubMed
    1. Xie B., Waters M.J., Schirra H.J. Investigating potential mechanisms of obesity by metabolomics. J. Biomed. Biotechnol. 2012;2012:805683. doi: 10.1155/2012/805683. - DOI - PMC - PubMed
    1. Singla P., Bardoloi A., Parkash A.A. Metabolic effects of obesity: A review. World J. Diabetes. 2010;1:76–88. doi: 10.4239/wjd.v1.i3.76. - DOI - PMC - PubMed
    1. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004;89:2548–2556. doi: 10.1210/jc.2004-0395. - DOI - PubMed

MeSH terms